CRISPR/Cas9 technology generated a TGG to CGC change resulting in a tryptophan to arginine substitution at amino acid 230 (W230R). This change corresponds to the W231R variant found in a pediatric patient with X-linked familial autoinflammatory syndrome. (J:328935)